The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

about

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.

P2860

Q38972503-CEF016D2-7553-4CF2-9131-2F3D2BCA1F16

P2860

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

Item

http://www.wikidata.org/entity/Q39905570

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

@en

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

@nl

type

Item

label

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

@en

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

@nl

prefLabel

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

@en

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

@nl

P1476

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation

@en

P2093

Bridget Elise Frain

http://www.w3.org/2001/XMLSchema#string

Ronald Castelino

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice

A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

P304

671-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029616637184

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luke R Bereznicki

P577

2016-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26994296

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

about

P2860

P2860

The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921